The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.

Yokota, Asumi; Huo, Li; Lan, Fengli; Wu, Jianqiang; Huang, Gang

Yokota, Asumi; Huo, Li; Lan, Fengli; Wu, Jianqiang; Huang, Gang.

Afiliación

Yokota A; Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Huo L; Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Lan F; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Wu J; Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Huang G; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Mol Cells ; 43(2): 145-152, 2020 Feb 29.

Article en En | MEDLINE | ID: mdl-31964134

Asunto(s)

Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética; Neoplasias Hematológicas/genética; Humanos; Mutación

Palabras clave

RUNX1 mutations; clinical incidence and prognosis; pathogenesis; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Subunidad alfa 2 del Factor de Unión al Sitio Principal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cells Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google